Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vericel (VCEL) Total Current Liabilities: 2010-2025

Historic Total Current Liabilities for Vericel (VCEL) over the last 15 years, with Sep 2025 value amounting to $45.6 million.

  • Vericel's Total Current Liabilities rose 10.25% to $45.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.6 million, marking a year-over-year increase of 10.25%. This contributed to the annual value of $50.3 million for FY2024, which is 9.92% up from last year.
  • As of Q3 2025, Vericel's Total Current Liabilities stood at $45.6 million, which was up 10.82% from $41.1 million recorded in Q2 2025.
  • Vericel's 5-year Total Current Liabilities high stood at $50.3 million for Q4 2024, and its period low was $18.8 million during Q3 2021.
  • In the last 3 years, Vericel's Total Current Liabilities had a median value of $41.1 million in 2025 and averaged $40.4 million.
  • As far as peak fluctuations go, Vericel's Total Current Liabilities dropped by 11.66% in 2021, and later surged by 43.80% in 2022.
  • Vericel's Total Current Liabilities (Quarterly) stood at $26.1 million in 2021, then spiked by 43.80% to $37.5 million in 2022, then rose by 22.12% to $45.7 million in 2023, then increased by 9.92% to $50.3 million in 2024, then increased by 10.25% to $45.6 million in 2025.
  • Its Total Current Liabilities was $45.6 million in Q3 2025, compared to $41.1 million in Q2 2025 and $39.4 million in Q1 2025.